Lifestyle modification decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men

Coronary Artery Disease

Volumn 24, Issue 7, 2013, Pages 583-588

  Maeda, Seiji ^a   Miyaki, Asako ^b   Kumagai, Hiroshi ^c   Eto, Miki ^c   So, Rina ^c   Tanaka, Kiyoji ^a   Ajisaka, Ryuichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Faculty of Medicine   (France)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

asymmetric dimethylarginine; dietary modification; exercise; obesity

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIET THERAPY; HEART RATE; HUMAN; LIFESTYLE MODIFICATION; MALE; OBESITY; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANIMALS; ANKLE BRACHIAL INDEX; ARGININE; BIOLOGICAL MARKERS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DOWN-REGULATION; EXERCISE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PULSE WAVE ANALYSIS; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS;

EID: 84885324074     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283647a99     Document Type: Article

References (26)

1. Safar ME, London GM. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J Hypertens 2000; 18:1527-1535.
2. Hodes RJ, Lakatta EG, McNeil CT. Another modifiable risk factor for cardiovascular disease? Some evidence points to arterial stiffness. J Am Geriatr Soc 1995; 43:581-582.
3. Rowe JW. Clinical consequences of age-related impairments in vascular compliance. Am J Cardiol 1987; 60:68G-71G.
4. Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese versus lean adults. Am J Cardiol 2003; 91:195-199.
5. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001; 38:429-433.
6. Miyaki A, Maeda S, Yoshizawa M, Misono M, Saito Y, Sasai H, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology 2009; 60:351-357.
7. Miyaki A, Maeda S, Yoshizawa M, Misono M, Saito Y, Sasai H, et al. Effect of habitual aerobic exercise on body weight and arteiral function in overweight and obese men. Am J Cardiol 2009; 6:823-828.
8. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
9. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105:213-217.
10. Sugawara J, Komine H, Hayashi K, Yoshizawa M, Yokoi T, Otsuki T, et al. Efffect of systemic nitric oxide synthase inhibition on arterial stiffness in humans. Hypertens Res 2007; 30:411-415.
11. Vallance P, Leone A, Calver A, Collier J, Mancada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20 (Suppl 12):S60-S62.
12. Vallance P, Leone A, Calver A, Collier J, Mancada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
13. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type diabetes mellitus. Am J Cardiol 2001; 88: 1201-1203.
14. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33:652-658.
15. Siervo M, Bluck LJC. In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome. Metabolism 2012; 61:680-688.
16. Yildizhan R, Ilhan GA, Yildizhan B, Kolusari A, Adali E, Bugdayci G. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril 2011; 96:246-250.
17. Kocak H, Oner-Iyidogan Y, Gurdol F, Oner P, Esin D. Serum asymmetric dimethylarginine and nitric oxide levels in obese postmenopausal women. J Clin Lab Anal 2011; 25:174-178.
18. Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, et al. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 2009; 27:2022-2027.
19. Sonmez A, Haymana C, Tapan S, Safer U, Celebi G, Ozturk O, et al. Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus. Endocrine 2010; 37:455-459.
20. Pa iva H, Lehtima ki T, Laakso J, Ruokonen I, Rantalaiho V, Wirta O, et al. Plasma concentrations of asymmetric-dimethyl-arginine in type diabetes associate with glycemic control and glomerular filtration rate but not with risk factor of vasculopathy. Metabolism 2003; 52:303-307.
21. Valkonen VP, Pa iva H, Salonen JT, Lakka TA, Lehtima ki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001; 358:2127-2128.
22. Van Guilder GP, Stauffer BL, Greiner JJ, DeSouza CA. Impaired endothelium-dependent vasodilation in overweight and obese adults humans is not limited to muscarinic receptor agonist. Am J Physiol Heart Circ Physiol 2008; 294:H1685-H1692.
23. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001; 88:1264-1269.
24. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-977.
25. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117:1658-1667.
26. Rigamonti AE, Agosti F, De Col A, Marazzi N, Lafortuna CL, Cella SG, et al. Changes in plasma levels of ghrelin, leptin, and other hormonal and metabolic parameters following standardized breakfast, lunch, and physical exercise before and after a multidisciplinary weight-reduction intervention in obese adolescents. J Endocrinol Invest 2010; 33:633-639.